UN delays cloning vote

Choice between total and partial bans on human embryo cloning put off for 2 years

Written byTheresa Tamkins
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

UNITED NATIONS, NY—A UN sharply divided on the issue of "therapeutic" cloning decided by a razor-thin margin yesterday to delay a vote for 2 years, rather than choose between two different cloning bans before the General Assembly.

Instead, on Thursday (November 6), the General Assembly voted 80 to 79 in favor of a procedural motion made by the Organization of the Islamic Conference (OIC) to put off voting on a cloning ban for 2 years, "to study all aspects and ramifications of the issue and come up with a clear view on the subject matter." Not all 191 members of the General Assembly were in attendance, and 15 member states present abstained from voting.

The vote caps nearly 2 years of contentious wrangling over a proposed UN convention to address the issue of human cloning. Opposing camps had come to a stalemate over whether the treaty should ban all forms ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies